CannaPharmaRx Inc
OTC:CPMD

Watchlist Manager
CannaPharmaRx Inc Logo
CannaPharmaRx Inc
OTC:CPMD
Watchlist
Price: 0.0088 USD Market Closed
Market Cap: 5.8m USD

CannaPharmaRx Inc
Operating Expenses

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

CannaPharmaRx Inc
Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
CannaPharmaRx Inc
OTC:CPMD
Operating Expenses
-$301.2k
CAGR 3-Years
51%
CAGR 5-Years
37%
CAGR 10-Years
29%
Bausch Health Companies Inc
TSX:BHC
Operating Expenses
-$5B
CAGR 3-Years
-5%
CAGR 5-Years
-2%
CAGR 10-Years
0%
Canopy Growth Corp
TSX:WEED
Operating Expenses
-CA$138.8m
CAGR 3-Years
35%
CAGR 5-Years
30%
CAGR 10-Years
-34%
Sundial Growers Inc
NASDAQ:SNDL
Operating Expenses
-CA$268.7m
CAGR 3-Years
-19%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Operating Expenses
-$77.1m
CAGR 3-Years
18%
CAGR 5-Years
11%
CAGR 10-Years
-54%
K
Knight Therapeutics Inc
TSX:GUD
Operating Expenses
-CA$187.4m
CAGR 3-Years
-7%
CAGR 5-Years
-13%
CAGR 10-Years
-33%
No Stocks Found

CannaPharmaRx Inc
Glance View

Market Cap
5.8m USD
Industry
Pharmaceuticals

CannaPharmaRx, Inc. engages in the research and manufacture of cannabinoid-based pharmaceuticals. The company is headquartered in Calgary, Alberta and currently employs 4 full-time employees. The principal activity of the Company is to negotiate, acquire and develop various cannabis cultivation projects throughout Canada. The firm's activities is centered around projects, such as the Great Northern Project, and the acquisition of Ramon Road Production Campus LLC. The firm is focused on producing wholesale cannabis and hemp for the medical market.

CPMD Intrinsic Value
0.0045 USD
Overvaluation 49%
Intrinsic Value
Price

See Also

What is CannaPharmaRx Inc's Operating Expenses?
Operating Expenses
-301.2k USD

Based on the financial report for Jun 30, 2025, CannaPharmaRx Inc's Operating Expenses amounts to -301.2k USD.

What is CannaPharmaRx Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
29%

Over the last year, the Operating Expenses growth was 55%. The average annual Operating Expenses growth rates for CannaPharmaRx Inc have been 51% over the past three years , 37% over the past five years , and 29% over the past ten years .

Back to Top